The detection of disease-specific GFAP fragments either alone or in combination with other biomarkers [70] will extend the utility of anti-GFAP antibodies for future patient-oriented research as well as experimental studies on animal- and cell-based models of AxD and possibly other related diseases where GFAP proteolysis is a prominent feature. Here, GFAP is linked to Alexander disease.